RAS-MAPK pathway disorders: Important causes of congenital heart disease, feeding difficulties, developmental delay and short stature

Archives of Disease in Childhood

Volumn 95, Issue 9, 2010, Pages 724-730

  Burkitt Wright, Emma M M ^a,b   Kerr, Bronwyn ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; RAS PROTEIN;

CONGENITAL HEART DISEASE; COSTELLO SYNDROME; DEVELOPMENTAL DISORDER; DISEASE COURSE; FEEDING DISORDER; GENE MUTATION; GENETIC CODE; GENETIC SCREENING; GENOTYPE; HUMAN; LEOPARD SYNDROME; NEUROFIBROMATOSIS; NOONAN SYNDROME; PHENOTYPE; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; SHORT STATURE; SYSTEMATIC REVIEW; CONGENITAL HEART MALFORMATION; GENETICS; GROWTH DISORDER; INFANT; MULTIPLE MALFORMATION SYNDROME; MUTATION; NEWBORN; ONCOGENE RAS; PRESCHOOL CHILD; SIGNAL TRANSDUCTION; SYNDROME;

ABNORMALITIES, MULTIPLE; CHILD, PRESCHOOL; DEVELOPMENTAL DISABILITIES; FEEDING AND EATING DISORDERS OF CHILDHOOD; GENES, RAS; GENOTYPE; GROWTH DISORDERS; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; INFANT, NEWBORN; MAP KINASE SIGNALING SYSTEM; MUTATION; PHENOTYPE; SYNDROME;

EID: 77955726794     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2009.160069     Document Type: Review

References (30)

1. Huson S. Neurofibromatosis: emerging phenotypes, mechanisms and management. Clin Med 2009;8:611-17.
2. van der Burgt I. Noonan syndrome. Orphanet J Rare Dis 2007;2:4.
3. Schubbert S, Shannon K, Bollag G. Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer 2007;7:295-308. (Pubitemid 46480970)
4. Fryer AE, Holt PJ, Hughes HE. The cardio-facio-cutaneous (CFC) syndrome and Noonan syndrome: are they the same? Am J Med Genet 1991;38:548-51.
5. Tidyman WE, Rauen KA. Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway. Expert Rev Mol Med 2008;10:e37.
6. Zenker M, Horn D, Wieczorek D, et al. SOS1 is the second most common Noonan gene but plays no major role in cardio-facio-cutaneous syndrome. J Med Genet 2007;44:651-6. (Pubitemid 47584760)
7. Cordeddu V, Di Schiavi E, Pennacchio LA, et al. Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair. Nat Genet 2009;41:1022-6.
8. Sarkozy A, Digilio MC, Dallapiccola B. Leopard syndrome. Orphanet J Rare Dis 2008;3:13.
9. Sarkozy A, Carta C, Moretti S, et al. Germline BRAF mutations in Noonan, Leopard, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum. Hum Mutat 2009;30:695-702.
10. De Luca A, Bottillo I, Sarkozy A, et al. NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome. Am J Hum Genet 2005;77:1092-101. (Pubitemid 41698528)
11. Thiel C, Wilken M, Zenker M, et al. Independent NF1 and PTPN11 mutations in a family with neurofibromatosis-Noonan syndrome. Am J Med Genet A 2009;149A:1263-7.
12. Brems H, Chmara M, Sahbatou M, et al. Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat Genet 2007;39:1120-6. (Pubitemid 47340658)
13. Lo IF, Brewer C, Shannon N, et al. Severe neonatal manifestations of Costello syndrome. J Med Genet 2008;45:167-71. (Pubitemid 351373746)
14. Kerr B, Delrue MA, Sigaudy S, et al. Genotype-phenotype correlation in Costello syndrome: HRAS mutation analysis in 43 cases. J Med Genet 2006;43:401-5.
15. Kerr B, Allanson J, Delrue MA, et al. The diagnosis of Costello syndrome: nomenclature in Ras/MAPK pathway disorders. Am J Med Genet A 2008;146A:1218-20. (Pubitemid 351628611)
16. Armour CM, Allanson JE. Further delineation of cardio-facio-cutaneous syndrome: clinical features of 38 individuals with proven mutations. J Med Genet 2008;45:249-54.
17. Al-Rahawan MM, Chute DJ, Sol-Church K, et al. Hepatoblastoma and heart transplantation in a patient with cardio-facio-cutaneous syndrome. Am J Med Genet A 2007;143A:1481-8.
18. Makita Y, Narumi Y, Yoshida M, et al. Leukemia in Cardio-facio-cutaneous (CFC) syndrome: a patient with a germline mutation in BRAF proto-oncogene. J Pediatr Hematol Oncol 2007;29:287-90. (Pubitemid 46707505)
19. Niihori T, Aoki Y, Narumi Y, et al. Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome. Nat Genet 2006;38:294-6.
20. Eerola I, Boon LM, Mulliken JB, et al. Capillary malformation- arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet 2003;73:1240-9. (Pubitemid 38037418)
21. Hart TC, Zhang Y, Gorry MC, et al. A mutation in the SOS1 gene causes hereditary gingival fibromatosis type 1. Am J Hum Genet 2002;70:943-54. (Pubitemid 34259310)
22. Sharif S, Ferner R, Birch JM, et al. Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy. J Clin Oncol 2006;24:2570-5.
23. Kuniba H, Pooh RK, Sasaki K, et al. Prenatal diagnosis of Costello syndrome using 3D ultrasonography amniocentesis confirmation of the rare HRAS mutation G12D. Am J Med Genet A 2009;149A:785-7.
24. Witters I, Denayer E, Brems H, et al. The cardiofaciocutaneous syndrome: prenatal findings in two patients. Prenat Diagn 2008;28:53-5.
25. Spits C, De Rycke M, Van Ranst N, et al. Preimplantation genetic diagnosis for neurofibromatosis type 1. Mol Hum Reprod 2005;11:381-7. (Pubitemid 41417873)
26. Sol-Church K, Stabley DL, Demmer LA, et al. Male-to-male transmission of Costello syndrome: G12S HRAS germline mutation inherited from a father with somatic mosaicism. Am J Med Genet A 2009;149A:315-21.
27. Søvik O, Schubbert S, Houge G, et al. De novo HRAS and KRAS mutations in two siblings with short stature and neuro-cardio-facio-cutaneous features. J Med Genet 2007;44:e84.
28. Korf BR. Statins, bone, and neurofibromatosis type 1. BMC Med 2008;6:22.
29. Nakamura T, Colbert M, Krenz M, et al. Mediating ERK 1/2 signaling rescues congenital heart defects in a mouse model of Noonan syndrome. J Clin Invest 2007;117:2123-32. (Pubitemid 47219557)
30. Schuhmacher AJ, Guerra C, Sauzeau V, et al. A mouse model for Costello syndrome reveals an Ang II-mediated hypertensive condition. J Clin Invest 2008;118:2169-79. (Pubitemid 351872335)